SILANES
Live / Registered — Registered and renewed (as of 21 May 2019)
What this means for you
Registered since 27 Apr 1999. The owner can stop confusingly similar uses in the classes it covers; it stays on the register as long as the owner keeps up the maintenance filings (next due by 27 Apr 2019).
Record
- Serial number
- 75176361
- Registration number
- 2241440
- Mark type
- Word mark
- Filed
- 03 Oct 1996
- Published for opposition
- 22 Sept 1998
- Registered
- 27 Apr 1999
- Next maintenance due
- 27 Apr 2019
- Attorney of record
- Jason L DeFrancesco
Goods and services
- Class 005 — Pharmaceuticals: pharmaceuticals, namely, injectable solutions, tablets, pills and capsules for adults and children, oral suspension, medicated syrup and ointment, all for treatment as a cough suppressant, and expectorant, [ activity against anaerobic bacteria, Trichomona vaginalis, Entamoeba histolytica, and giardia lamblia, ] as an antifungal agent for treatment of Oropharyngeal and esophageal candidiasis, [ candidial urinary tract infections, peritonitis and systemic candidal infections, candidemia, disseminated candidiasis and pneumonia, cryptococcal meningitis, candidal genital tract infections, ] as an analgesis anti-inflamatory non steroidal inhibitor of prostaglandin synthetase, [ analgesic and minor tranquilizer, active immunization against tetanus, peripheral neuritis, neuralgias, peripheral neuritis, neuralgias and haematopoietic, antifungal agent for treatment of systemic blastomycosis, histoplasmosis paracoccidloidomycosis, fungal infection of the gastrointestinal tract and tinea infections of the skin, and nails, sulphonylurea and biguanide, hipoglycaemic agent, activity against trichomonas vaginalis, entamoeba histolytica and Giardia lamblia, anaerobic bacteria, ] histamine H1-receptor antagonist and prophylactic treatment of asthma, and treatment of allergic conditions such as rhinitis and conjuntivitis,[ analgesic, ] anti-inflamatory non steroidal, for inhibiting prostaglanding synthetase, [ analgesic, anti-inflammatory non steroidal, inhibitor of prostaglandin synthetase ] and muscle relaxant, analgesic, antipyretic, [ sulphonylurea hipoglycaemic agent, for inhibiting as an angiotensin-converting enzyme, treatment of congestive heart failure and asymptomatic left ventricular dysfunction, diuretic treatment of congestive heart failure, hypertension, cardiac, renal hepatogenic oedema, peripheral neuritis, neuralgias and analgesic, ] a broad spectrum antibiotic, effective against a wide range of Gram positive and Gram negative aerobic and anaerobic bacterias, [ histamin H2-receptor antagonist in the treatment of gastric an duodenal ulcer, Zollinger-Ellison syndrome, iron deficiency and anemia for children or adults, ] anixolytic, anticonvulsant, sedative, muscle relaxant, [ histamine H2-receptor antagonist in the treatment of gastric and duodenal ulcer Zollinger-Ellison syndrome, ] multivitamin treatment and prevention of vitamin B1-B6-B12 deficiency, [ tricyclic antidepressant, treatment of nocturnal enuresis in children, inhibits angiotensin-converting enzyme, ] treatment of hypertension and congestive heart failure, treatment and prevention of vitamic C deficiency, treatment and prevention of seborrhoea and dandruff, analgesic no narcotic
Owner
- LABORATORIOS SILANES, S.A. DE C.V., Ciudad de México, MX
- LABORATORIOS SILANES, S.A. DE C.V., Mexico City, MX
- LABORATORIOS SILANES, S.A. DE C.V., Mexico City, MX
Prosecution history
- 23 Apr 2022 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 23 Apr 2022 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 23 Apr 2022 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 16 Jan 2020 — ATTORNEY/DOM.REP.REVOKED AND/OR APPOINTED
- 16 Jan 2020 — TEAS REVOKE/APP/CHANGE ADDR OF ATTY/DOM REP RECEIVED
- 21 May 2019 — NOTICE OF ACCEPTANCE OF SEC. 8 & 9 - E-MAILED
- 21 May 2019 — REGISTERED AND RENEWED (SECOND RENEWAL - 10 YRS)
- 21 May 2019 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 20 May 2019 — CASE ASSIGNED TO POST REGISTRATION PARALEGAL
- 16 Apr 2019 — TEAS CHANGE OF CORRESPONDENCE RECEIVED
- 16 Apr 2019 — TEAS SECTION 8 & 9 RECEIVED
- 27 Apr 2018 — COURTESY REMINDER - SEC. 8 (10-YR)/SEC. 9 E-MAILED
- 26 Feb 2009 — REGISTERED AND RENEWED (FIRST RENEWAL - 10 YRS)
- 26 Feb 2009 — REGISTERED - SEC. 8 (10-YR) ACCEPTED/SEC. 9 GRANTED
- 19 Feb 2009 — TEAS SECTION 8 & 9 RECEIVED